Myxoid spindle cell sarcoma with ETV6-NTRK3 fusion

被引：0

作者：

Kyriazoglou, Anastasios ^{[1
]}

Dimitriadis, Efhtymios ^{[2
]}

Mahaira, Luiza ^{[2
]}

Kotsantis, John ^{[1
]}

Kouloulias, Vasileios ^{[3
]}

Kontogeorgakos, Vasileios ^{[4
]}

Psyrri, Amanda ^{[1
]}

Agrogiannis, Georgios ^{[5
]}

机构：

[1] Attikon Univ Hosp, Propaedeut Dept Med 2, 1 Rimini St, Athens 12462, Greece

[2] Agios Savvas Anticanc Hosp, Dept Genet, Athens, Greece

[3] Attikon Univ Hosp, Dept Radiotherapy, Chaidari, Greece

[4] Attikon Univ Gen Hosp, Dept Orthopaed Surg 1, Chaidari, Attica, Greece

[5] Natl & Kapodistrian Univ Athens, Sch Med, Dept Pathol 1, Athens, Greece

来源：

CANCER GENETICS | 2022年 / 268卷

关键词：

NTRK alteration; Myxoid spindle cell sarcoma; ETV6; NTRK3; Sarcoma genetics; POSITIVE SOLID TUMORS; OF-THE-ART; MYXOFIBROSARCOMA; BIOLOGY; TISSUE;

D O I：

10.1016/j.cancergen.2022.09.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Myxoid spindle cell sarcoma is a rare sarcoma with a demanding histopathologic diagnosis due to the absence of pathognomic immunohistochemistry markers. Genetics include complex karyotypic alterations without characteristic molecular abnormalities for this entity. NTRK alterations are rare findings with great clinical importance since they can be therapeutically targeted with two NTRK inhibitors. Herein we present a case of an adult unclassified myxoid spindle cell sarcoma with ETV6/NTRK3 fusion gene, which is a molecular finding characteristic for infantile fibrosarcoma. (c) 2022 Elsevier Inc. All rights reserved.

引用

页码：1 / 4

页数：4

共 50 条

[41] Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland
Diana Bell
Renata Ferrarotto
Li Liang
Ryan P. Goepfert
Jie Li
Jing Ning
Russell Broaddus
Randal S. Weber
Adel K. El-Naggar
Virchows Archiv, 2020, 476 : 295 - 305
[42] High‐grade Salivary Gland Adenocarcinoma Harboring ETV6-NTRK3 Fusion: Defined by Morphology or Molecular Aberration?
Niels J. Rupp
Constanze Nemes
Elisabeth J. Rushing
Gerhard F. Huber
Sandra N. Freiberger
Head and Neck Pathology, 2021, 15 : 1082 - 1084
[43] Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
Lae, Marick
Freneaux, Paul
Sastre-Garau, Xavier
Chouchane, Olfa
Sigal-Zafrani, Brigitte
Vincent-Salomon, Anne
MODERN PATHOLOGY, 2009, 22 (02) : 291 - 298
[44] Primary Cutaneous Secretory Carcinoma with ETV6-NTRK3 Gene-Fusion: A Case Report and Literature Review
Carstens, A.
Lewis, J.
Tremlett, J.
White, R.
Bragg, T.
Joshi, A.
JOURNAL OF PATHOLOGY, 2021, 255 : S41 - S41
[45] Pan-Trk Immunoreactivity, ETV6-NTRK3 Fusion Variants and RET Rearrangement in Salivary Secretory Carcinoma
Yamamoto, Hidetaka
Nozaki, Yui
Oda, Yoshinao
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1241 - 1241
[46] Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma
Seethala, Raja R.
Chiosea, Simion I.
Liu, Cheng Z.
Nikiforova, Marina
Nikiforov, Yuri E.
MODERN PATHOLOGY, 2016, 29 : 154A - 154A
[47] Clinical and Morphologic Features of ETV6-NTRK3 Translocated Papillary Thyroid Carcinoma
Seethala, Raja R.
Chiosea, Simion I.
Liu, Cheng Z.
Nikiforova, Marina
Nikiforov, Yuri E.
LABORATORY INVESTIGATION, 2016, 96 : 154A - 154A
[48] Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation
Amin, Sapna M.
Beattie, Adam
Ling, Xia
Jennings, Lawrence J.
Guitart, Joan
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2016, 38 (11) : 842 - 845
[49] Role of the ETV6-NTRK3 transcript in the differential diagnosis of myofibroblastic lesions of childhood
Alaggio, R
Sartori, F
Bonandini, E
Dall Igna, P
Ninfo, V
Rosolen, A
LABORATORY INVESTIGATION, 2003, 83 (01) : 300A - 300A
[50] Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement
El Demellawy, Dina
Cundiff, Caitlin A.
Nasr, Ahmed
Ozolek, John A.
Elawabdeh, Nancy
Caltharp, Shelley A.
Masoudian, Pourya
Sullivan, Katrina J.
de Nanassy, Joseph
Shehata, Bahig M.
PATHOLOGY, 2016, 48 (01) : 47 - 50

← 1 2 3 4 5 →